Kohshin Washiyama

Associate Professor

Fukushima Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kohshin Washiyama is an Associate Professor at Fukushima Medical University in Japan. His research focuses on radiotheranostics, particularly in the development of novel ligands and probes that enhance therapeutic efficacy for cancer treatment. Recent publications highlight advancements in radiochemical compounds, imaging techniques, and targeted therapies using novel radioisotopes.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Masashi Takahashi

Professor

Toho University

JAPAN

View details

Kazuma Ogawa

Kanazawa University

JAPAN

View details

Mitsuhiro Shinada

National Institutes for Quantum and Radiological Science and Technology

JAPAN

View details

Noboru Oriuchi

Fukushima Medical University

JAPAN

View details

Hiroki Matsumoto

Professor

The Univeristy of Tokyo

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kohshin Washiyama

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics

In Vivo Stability Improvement of Astatobenzene Derivatives by Introducing Neighboring Substituents

Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At)

Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma

Development of a phoswich detector composed of ZnS(Ag) and YAP(Ce) for astatine-211 imaging

Evaluation of aminopolycarboxylate chelators for whole-body clearance of free<sup>225</sup>ac: A feasibility study to reduce unexpected radiation exposure during targeted alpha therapy

Adsorption temperature of volatile astatine species formed via dry distillation in a glass tube

68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides

Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody

Collaborators (5)

Masashi Takahashi

Kazuma Ogawa

Mitsuhiro Shinada

Noboru Oriuchi

Hiroki Matsumoto

Make your next move.